The WI-1 adhesin blocks phagocyte TNF-alpha production, imparting pathogenicity on Blastomyces dermatitidis

J Immunol. 2001 Feb 15;166(4):2665-73. doi: 10.4049/jimmunol.166.4.2665.

Abstract

The WI-1 adhesin is indispensable for pathogenicity of Blastomyces dermatitidis and is thought to promote pulmonary infection by fixing yeast to lung tissue and cells. Recent findings suggest that WI-1 confers pathogenicity by mechanisms in addition to adherence. Here, we investigated whether WI-1 modulates host immunity by altering production of pro-inflammatory cytokines. Production of TNF-alpha in lung alveolar fluids of mice infected with B. dermatitidis was severalfold higher for WI-1 knockout yeast compared with wild-type yeast, and in vitro coculture of unseparated lung cells with these isogenic yeast disclosed similar differences. Upon coculture with purified macrophages and neutrophils, wild-type yeast blocked TNF-alpha production, yet WI-1 knockout yeast stimulated production. Coating knockout yeast with purified WI-1 converted them from stimulating TNF-alpha production to inhibiting production. Addition of purified WI-1 into stimulated phagocyte cultures led to concentration-dependent inhibition of TNF-alpha production. Neutralization of TNF-alpha in vivo exacerbated experimental pulmonary infection, particularly for the nonpathogenic WI-1 knockout yeast. Inducing increased TNF-alpha levels in the lung by adenovirus-vectored gene therapy controlled infection with wild-type yeast. Thus, the WI-1 adhesin on yeast modulates host immunity through blocking TNF-alpha production by phagocytes, which fosters progression of pulmonary infection.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenoviridae / genetics
  • Adenoviridae / immunology
  • Animals
  • Blastomyces / genetics
  • Blastomyces / immunology*
  • Blastomyces / pathogenicity*
  • Blastomycosis / immunology
  • Blastomycosis / microbiology
  • Blastomycosis / therapy
  • Cell Adhesion / immunology
  • Cells, Cultured
  • Fungal Proteins / genetics
  • Fungal Proteins / metabolism
  • Fungal Proteins / toxicity*
  • Genetic Therapy
  • Glycoproteins / deficiency
  • Glycoproteins / genetics
  • Glycoproteins / metabolism
  • Glycoproteins / toxicity*
  • Intubation, Intratracheal
  • Macrophages, Alveolar / immunology
  • Macrophages, Alveolar / metabolism
  • Macrophages, Alveolar / microbiology
  • Macrophages, Peritoneal / immunology
  • Macrophages, Peritoneal / metabolism
  • Macrophages, Peritoneal / microbiology
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Neutrophils / immunology
  • Neutrophils / metabolism
  • Neutrophils / microbiology
  • Phagocytosis / genetics
  • Phagocytosis / immunology*
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / therapeutic use
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Tumor Necrosis Factor-alpha / biosynthesis*
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / physiology

Substances

  • Fungal Proteins
  • Glycoproteins
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha